Outcomes of Biologic Use in Asian Compared with Non-Hispanic White Adult Psoriasis Patients from the CorEvitas Psoriasis Registry.
Chen YuGang WangRussel T BurgeErjia YeGuanshen DouJinnan LiRyan W HarrisonRobert R McLeanSamantha J KertiJerry BagelPublished in: Dermatology and therapy (2022)
Unadjusted differences in biologic therapy effectiveness between Asians compared with White patients were likely explained by differences in demographic, lifestyle, and psoriatic disease characteristics between groups. However, Asians still experienced lesser improvements in skin-related quality of life, even after adjustment.
Keyphrases
- end stage renal disease
- rheumatoid arthritis
- ejection fraction
- newly diagnosed
- prognostic factors
- peritoneal dialysis
- systematic review
- cardiovascular disease
- metabolic syndrome
- stem cells
- physical activity
- patient reported outcomes
- systemic lupus erythematosus
- skeletal muscle
- young adults
- insulin resistance
- bone marrow
- smoking cessation
- atopic dermatitis